课题基金 / 基金详情

Combining structure and function in the nicotinic superfamily: the single-channel activation mechanism for the prokaryotic model channel ELIC

Combining structure and function in the nicotinic superfamily: the single-channel activation mechanism for the prokaryotic model channel ELIC
烟碱超家族结构与功能的结合:原核模型通道 ELIC 的单通道激活机制
批准号:
BB/J005312/1
负责人:
Lucia Sivilotti
金额:
$50.33万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --

项目摘要

项目成果

Lucia Sivilotti的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of our work is to understand how ion channels function as molecules. The key to this is to know the 3-D structure of the channel (by X-ray crystallography) and to find out how this structure moves when the channel is activated, mainly by recording its electrical activity. It is rarely possible to get both sorts of information for the same molecule. New data mean that this is now possible for the group of channels we work on.Ion channels are proteins coded in our genome and are essential components of many cells in our bodies. For instance, they allow cells to communicate with each other at cell-to-cell junctions called synapses. This is essential not only in the brain but also to in the rest of our bodies where it allows the appropriate commands to reach muscles in our limbs and to regulate our blood pressure and heart rate. Channels also allow each neurone to process the information it receives from other neurones. Channels are important for normal human physiology and for disease. Mutations in the genes that code for channels can damage channel function and produce inherited human disease, such as cystic fibrosis. In addition to that, many drugs used for common diseases or in anaesthesia act by binding to channels. In particular, the group of channels that we study, the nicotinic superfamily, are targeted by sleeping pills, drugs for epilepsy, nicotine in tobacco and some insecticides. There are two main sources of information about channels: the first is X-ray crystallography, which provides us with information about the shape of the protein and the second is electrophysiology, which measures the electrical signal the channel produces. In the most advanced form, which is our special expertise, this technique detects the current that passes through a single protein molecule in real time, even though it is very small (more than a billion times smaller than the current in a kettle). This technique is very useful, because it allows us to measure the speed with which molecular events in the function of the channel occur. Hence we can understand channel function precisely as a chemical reaction, quantifying each step, from the binding of the neurotransmitter to the opening of the channel. By doing this in channels in the nicotinic group, we have found how tightly neurotransmitters and drugs bind to the protein when it is active or inactive and why some drugs act more strongly than others. Ideally we should study the structure and the function of the SAME channel. This is not easy because channels are difficult to crystallize, and so far we have good structures only for three channels in this group (GLIC, ELIC and GluCl). Of these, GLIC produces electrical signals that are too small for good electrophysiology. As for GluCl, we don't know how good its signal is (the structure has literally just been published). A potential problem with GluCl is that it does not open like all other channels in the group do, in response to a neurotransmitter-like compound, but it requires TWO different substances, binding to different places, so we don't know how good a model it will be.Until now ELIC was thought not to be able to open. Other scientists have now discovered the right substances that activate ELIC, and it turns out to open well and to give an excellent, big signal. We want to apply the single-molecule recording that is our special skill to ELIC, so that we can understand how it functions as a molecule. Once we have that, we can push our understanding much further, because we can refer to precise structural information (available for ELIC) in interpreting the effect of drugs and the effect of mutations in the channel. This is basic research but it is what is needed if we want to explain what bits of the molecule change and how they move when the channel is activated, where exactly drugs bind to the protein and how we should modify the structure of drugs in order to make them more effective.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
ELIC channel activation and block by propylamine
丙胺激活和阻断 ELIC 通道
DOI: --
发表时间: 2013
期刊: Proceedings of the Physiological Society
影响因子: --
作者: [Marabelli A]
通讯作者: Marabelli A
Activation Mechanism of Elic by Propylamine
丙胺激活 Elic 的机制
DOI: 10.1016/j.bpj.2013.11.3036
发表时间: 2014
期刊: Biophysical Journal
影响因子: 3.4
作者: [Marabelli A]
通讯作者: Marabelli A
DOI: 10.1371/journal.pbio.1001429
发表时间: 2012
期刊: PLoS biology
影响因子: 9.8
作者: [Zimmermann I, Marabelli A, Bertozzi C, Sivilotti LG, Dutzler R]
通讯作者: Dutzler R
DOI: --
发表时间:
期刊: Gordon Research Conference on Ion channels 2012
影响因子: --
作者: [Marabelli A]
通讯作者: Marabelli A
6
    Single molecule quantification of the activation, biophysics and pharmacology of GlyREM, a new structural model for pentameric ligand-gated channels
    • 批准号:
      MR/R009074/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $49.66万
    • 财政年份:
      2018
    • 负责人:
      Lucia Sivilotti
    • 依托单位:
    Probing the dynamics of agonist drug interaction with Cys-loop channels by single-molecule recording
    • 批准号:
      MR/J007110/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $68.56万
    • 财政年份:
      2012
    • 负责人:
      Lucia Sivilotti
    • 依托单位:
    国内基金
    海外基金
    Rh-N4位点催化醇类氧化反应的微观机制与构效关系研究
    • 批准号:
      22302208
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30.00万元
    • 批准年份:
      2023
    • 负责人:
      王翔
    • 依托单位:
    体内亚核小体图谱的绘制及其调控机制研究
    • 批准号:
      32000423
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      温增麒
    • 依托单位:
    水稻H3K27me3标记基因的三维基因组结构解析及其调控抽穗期的机理研究
    • 批准号:
      32070612
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      李兴旺
    • 依托单位:
    稻瘟病菌中蛋白激酶MoCK2参与附着胞极性生长影响致病性的初步探索
    • 批准号:
      32060597
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      35.0万元
    • 批准年份:
      2020
    • 负责人:
      张连虎
    • 依托单位: